CD1D and neoplasm: CD1d expressing APCs treated with GD3 significantly suppress NKT cell activation, suggesting a direct role of GD3 as a lipid antigen enriched in tumor in suppressing anti-tumor immunity in an ovarian cancer model through presentation by CD1d to NKT cells.